看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
6 q- j8 L; c. b" b. M4 t- f" _6 [
, Z% X9 m H' a
& C2 U4 ?; D* W- ~$ D# UCurrently available feasibility data for possible combination strategies.
0 W8 j2 B6 |" r% l3 \$ h————————————————————————————————
6 k% U1 k7 H- MCombination Feasibility according to preliminary data # o0 j" E" f) I
——————————————————————————————————9 H) g# ]9 z7 K) b {- O0 T# s
Bevacizumab + sorafenib Yes, reduced dose
' H, t, C- V* D, }; j$ Q. E: z" PBevacizumab + sunitinib† No ' y2 ]8 z, `* e, w$ i& r
Bevacizumab + temsirolimus Yes
. @* N- h7 P5 G* @* |+ M! H4 \Bevacizumab + everolimus Yes " M( o4 [" r; w$ s! g% R$ p8 c* r- ?
Sorafenib + sunitinib ?
& X% L! \* q1 z& i" G3 p: Z2 K: MSorafenib + temsirolimus Yes, reduced dose
5 I6 i: \) Y- d: a5 hSorafenib + everolimus Yes, reduced dose
6 O# [& g' E$ e) ~3 A# YSunitinib + temsirolimus† No
1 v# X/ \& v$ A/ z( \) `Sunitinib + everolimus ?
' C3 Q6 [6 j$ w/ D9 n& [: gTemsirolimus + everolimus ? ( W! d# T1 k: q- b4 T
————————————————————
) V7 y- G5 H- H- D( m9 B$ F7 Q†Led to US FDA warning.
; k" x8 {+ |* E?: As yet unattempted combination.
3 {" _' A5 q% H1 K( J: }$ s |